Protein Phosphatase 4 Promotes Hepatocyte Lipoapoptosis by Regulating RAC1/MLK3/JNK Pathway
Open Access
- 15 June 2021
- journal article
- research article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2021, 1-16
- https://doi.org/10.1155/2021/5550498
Abstract
Lipotoxicity-induced apoptosis, also referred to as lipoapoptosis, is one of the important initial factors promoting the progression from hepatosteatosis to nonalcoholic steatohepatitis (NASH). Saturated free fatty acids (SFAs), which are increased significantly in NASH, are directly hepatotoxic which induce hepatocyte lipoapoptosis. Previously, we reported that protein phosphatase 4 (PP4) was a novel regulator of hepatic insulin resistance and lipid metabolism, but its role in hepatic lipoapoptosis remains unexplored. In this study, we found out that PP4 was upregulated in the livers of western diet-fed-induced NASH mice and SFA-treated murine primary hepatocytes and HepG2 cells. In addition, we found for the first time that suppression of PP4 decreased SFA-induced JNK activation and expression of key modulators of hepatocyte lipoapoptosis including p53-upregulated modulator of apoptosis (PUMA) and Bcl-2-interacting mediator (Bim) and reduced hepatocyte lipoapoptosis level as well both in vitro and in vivo. Further study revealed that PP4 induced JNK activation and lipoapoptosis-related protein expression by regulating the RAC1/MLK3 pathway instead of the PERK/CHOP pathway. The effects of palmitate-treated and PP4-induced lipoapoptosis pathway activation were largely abolished by RAC1 inhibition. Moreover, we identified that PP4 interacted with RAC1 and regulated GTPase activity of RAC1. In conclusion, these results demonstrated that PP4 was a novel regulator of hepatocyte lipoapoptosis and mediated hepatocyte lipoapoptosis by regulating the RAC1/MLK3/JNK signaling pathway. Our finding provided new insights into the mechanisms of this process.Funding Information
- Qinghai Science and Technology Foundation (2019-ZJ-922, 2018RC310025, BJ-2018-138, 7212086, 7182144, 2018YFC2000100, 81470427, 81270495, 81770228, 81600618, 81770858)
This publication has 28 references indexed in Scilit:
- Apoptosis and necroptosis in the liver: a matter of life and deathNature Reviews Gastroenterology & Hepatology, 2018
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategiesThe Lancet Diabetes & Endocrinology, 2018
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesisJournal of Lipid Research, 2016
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver diseaseMetabolism, 2016
- Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosisCell Death & Differentiation, 2014
- Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet‐induced steatohepatitisLiver International, 2013
- Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytesJournal of Hepatology, 2012
- JNK1-dependent PUMA Expression Contributes to Hepatocyte LipoapoptosisOnline Journal of Public Health Informatics, 2009
- Free Fatty Acids Induce JNK-dependent Hepatocyte LipoapoptosisOnline Journal of Public Health Informatics, 2006
- Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalitiesGastroenterology, 2001